Lebanon VA Medical Center Surgical Clinic 1700 S Lincoln Ave, Lebanon, PA 17042 7172726621 (phone), 7172286118 (fax)
Education:
Medical School Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) Graduated: 1982
Procedures:
Bone Marrow Biopsy Chemotherapy
Conditions:
Anemia Iron Deficiency Anemia Non-Hodgkin's Lymphoma Breast Neoplasm, Malignant Hemolytic Anemia
Languages:
English
Description:
Dr. Liu graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Lebanon, PA and specializes in Hematology/Oncology and Internal Medicine. Dr. Liu is affiliated with Lebanon VA Medical Center.
Garfield Health Center 210 N Garfield Ave STE 203, Monterey Park, CA 91754 6263077397 (phone), 6263071807 (fax)
Education:
Medical School Hunan Med Univ, Changsha City, Hunan, China Graduated: 1985
Languages:
Chinese English Spanish Vietnamese
Description:
Dr. Liu graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1985. She works in Monterey Park, CA and specializes in Internal Medicine. Dr. Liu is affiliated with Garfield Medical Center and Pacific Alliance Medical Center.
Tona M. Gilmer - Research Triangle Park NC, US Li Liu - King of Prussia PA, US Hong Shi - King of Prussia PA, US
International Classification:
A61K 31/5377 A61K 31/47 A61K 39/395 A61P 35/04
US Classification:
4241331, 514312, 5142352, 5142345, 4241431
Abstract:
The present invention relates to a method of treating cancer in a patient comprising administering to the patient therapeutically effective amounts of:a) a compound of formula A:or a pharmaceutically acceptable salt thereof, wherein R-R, p, and q are as defined; and(b) an erbB inhibitor that inhibits erbB-1 or erbB-2 or erbB-3 receptor or a combination thereof. The method of the present invention addresses a need in the art with the discovery of a combination therapy that shows evidence of being a more effective therapy than previously disclosed therapies.
Tona M. Gilmer - Durham NC, US Li Liu - King of Prussia PA, US James Greger - King of Prussia PA, US
International Classification:
A61K 31/517 A61P 35/00
US Classification:
51425219
Abstract:
The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and at least one additional anti-neoplastic compound. In particular, the method relates to a methods of treating cancers by administration of N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine and salts and solvates thereof in combination with at least one additional anti-neoplastic compound.
Tona M. Gilmer - Research Triangle Park NC, US Li Liu - King of Prussia PA, US
International Classification:
A61K 31/517 A61K 31/501
US Classification:
51425204
Abstract:
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine, or a pharmaceutically acceptable hydrate and/or salt thereof, and 2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.
Tona M. Gilmer - Research Triangle Park NC, US Rakesh Kumar - Collegeville PA, US Li Liu - King of Prussia PA, US
International Classification:
A61K 31/519 A61K 31/506
US Classification:
5142641
Abstract:
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy; -2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.